We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: Geographic Atrophy
MedXY News
EnglishTag

Geographic Atrophy

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Two-Year Outcomes of Intravitreal Pegcetacoplan in Managing Geographic Atrophy: Real-World Clinical Experience
newsIntravitreal Therapypegcetacoplan

Two-Year Outcomes of Intravitreal Pegcetacoplan in Managing Geographic Atrophy: Real-World Clinical Experience

By MedXY|Sep 17, 2026

Intravitreal pegcetacoplan significantly slowed geographic atrophy progression by 41% over two years, maintaining efficacy in clinical practice for AMD patients, with stable visual acuity decline and manageable safety.

Central Geographic Atrophy Extent Predicts Vision-Related Quality of Life in Age-Related Macular Degeneration
newsVision-Related Quality of Liferetinal imaging
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story

Central Geographic Atrophy Extent Predicts Vision-Related Quality of Life in Age-Related Macular Degeneration

By MedXY|Aug 24, 2026

Vision-related quality of life in geographic atrophy secondary to AMD is most strongly linked to lesion extent within a 2.5-mm central retinal zone, emphasizing targeted structural assessment for functional impact.

Distinct Geographic Atrophy Phenotypes in AMD: Characterizing Growth Patterns and Clinical Implications
newsFundus AutofluorescencePhenotypes

Distinct Geographic Atrophy Phenotypes in AMD: Characterizing Growth Patterns and Clinical Implications

By MedXY|Aug 23, 2026

This study identifies three candidate geographic atrophy phenotypes in age-related macular degeneration, revealing distinct growth rates and severity, with implications for prognosis and clinical trials.

Avacincaptad Pegol Demonstrates Efficacy in Slowing Photoreceptor Loss in Geographic Atrophy via Ellipsoid Zone Preservation
newsage-related macular degenerationAvacincaptad pegol

Avacincaptad Pegol Demonstrates Efficacy in Slowing Photoreceptor Loss in Geographic Atrophy via Ellipsoid Zone Preservation

By MedXY|Jul 2, 2026

Avacincaptad pegol significantly reduces progression of ellipsoid zone degradation and geographic atrophy lesion growth, highlighting its potential to preserve photoreceptor integrity in AMD patients.

Optimizing Geographic Atrophy Clinical Trial Design: The Role of Run-In Phases, Single-Arm Architectures, and Functional Endpoints
Clinical UpdatesGeographic Atrophyophthalmology

Optimizing Geographic Atrophy Clinical Trial Design: The Role of Run-In Phases, Single-Arm Architectures, and Functional Endpoints

By MedXY|May 20, 2026

This review synthesizes evidence on improving geographic atrophy trial efficiency through innovative run-in phases, single-arm designs, and superior functional biomarkers like microperimetry to reduce required sample sizes.

Challenging the Assumption: Fellow-Eye Correlations in Geographic Atrophy Progression Prove Modest at Best
newsAMD ProgressionAREDS2

Challenging the Assumption: Fellow-Eye Correlations in Geographic Atrophy Progression Prove Modest at Best

By MedXY|Apr 11, 2026

A post hoc analysis of AREDS2 reveals that geographic atrophy enlargement rates between fellow eyes show only modest correlations, challenging the common assumption that bilateral GA progresses similarly. The findings have important implica

Beyond Total Area: The GAWAIN Index Bridges the Gap Between Retinal Structure and Functional Vision in Geographic Atrophy
newsclinical trialsGeographic Atrophy

Beyond Total Area: The GAWAIN Index Bridges the Gap Between Retinal Structure and Functional Vision in Geographic Atrophy

By MedXY|Jan 30, 2026

Researchers have developed and validated GAWAIN, a novel structural measure for geographic atrophy that weights macular regions by their functional importance. This index correlates significantly better with visual acuity than traditional a

Restoring Vision in Geographic Atrophy: Subretinal Photovoltaic Implants Achieve Significant Visual Gains in Landmark Clinical Trial
newsAMDGeographic Atrophy

Restoring Vision in Geographic Atrophy: Subretinal Photovoltaic Implants Achieve Significant Visual Gains in Landmark Clinical Trial

By MedXY|Jan 23, 2026

A groundbreaking study published in NEJM demonstrates that the PRIMA subretinal photovoltaic system significantly improves visual acuity in patients with geographic atrophy, marking a major milestone in restorative ophthalmology.

Understanding Patient Acceptance of Complement Inhibitor Therapy in Geographic Atrophy
OphthalmologyComplement InhibitorsGeographic Atrophy

Understanding Patient Acceptance of Complement Inhibitor Therapy in Geographic Atrophy

By MedXY|Oct 9, 2025

A UK study reveals most patients with geographic atrophy are open to intravitreal complement inhibitor injections if these treatments offer vision improvement, highlighting the vital role of functional benefits in therapy acceptance.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities